Advertisement
Screener

VIEMED HEALTHCARE, INC. (VMD) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

VIEMED HEALTHCARE, INC. Stock-Based Compensation

VIEMED HEALTHCARE, INC. (VMD) reported Stock-Based Compensation of $4.48 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-03

  • VIEMED HEALTHCARE, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $2.03M, a 13.20% decline year-over-year.
  • VIEMED HEALTHCARE, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $2.45M, a 6.06% increase year-over-year.
  • VIEMED HEALTHCARE, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $2.30M, a 51.22% increase year-over-year.
  • VIEMED HEALTHCARE, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.18M, a 27.34% increase year-over-year.
  • VIEMED HEALTHCARE, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $9.13M, a 45.30% increase from fiscal 2024.
  • VIEMED HEALTHCARE, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $6.29M, a 7.45% increase from fiscal 2023.
  • VIEMED HEALTHCARE, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $5.85M, a 12.44% increase from fiscal 2022.
  • VIEMED HEALTHCARE, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $5.20M, a 1.01% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2026-06-30$2.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03
$4.48M
10-Q · filed 2026-08-03
$6.78M
derived: sum of 3 quarters · filed 2026-08-03
$8.96M
derived: sum of 4 quarters · filed 2026-08-03
2026-03-31$2.45M
10-Q · filed 2026-05-05
$4.75M
derived: sum of 2 quarters · filed 2026-05-05
$6.93M
derived: sum of 3 quarters · filed 2026-05-05
$9.27M
derived: sum of 4 quarters · filed 2026-08-03
2025-12-31$2.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
$4.48M
derived: sum of 2 quarters · filed 2026-03-04
$6.82M
derived: sum of 3 quarters · filed 2026-08-03
$9.13M
10-K · filed 2026-03-04
2025-09-30$2.18M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$4.52M
derived: sum of 2 quarters · filed 2026-08-03
$6.83M
10-Q · filed 2025-11-05
$8.35M
derived: sum of 4 quarters · filed 2026-08-03
2025-06-30$2.34M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03
$4.65M
10-Q · filed 2026-08-03
$6.17M
derived: sum of 3 quarters · filed 2026-08-03
$7.88M
derived: sum of 4 quarters · filed 2026-08-03
2025-03-31$2.31M
10-Q · filed 2026-05-05
$3.83M
derived: sum of 2 quarters · filed 2026-05-05
$5.54M
derived: sum of 3 quarters · filed 2026-05-05
$7.16M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$1.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
$3.23M
derived: sum of 2 quarters · filed 2026-03-04
$4.85M
derived: sum of 3 quarters · filed 2026-03-04
$6.29M
10-K · filed 2026-03-04
2024-09-30$1.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$3.33M
derived: sum of 2 quarters · filed 2025-11-05
$4.76M
10-Q · filed 2025-11-05
$6.30M
derived: sum of 4 quarters · filed 2026-03-04
2024-06-30$1.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$3.05M
10-Q · filed 2025-08-06
$4.59M
derived: sum of 3 quarters · filed 2026-03-04
$6.04M
derived: sum of 4 quarters · filed 2026-03-04
2024-03-31$1.43M
10-Q · filed 2025-05-07
$2.97M
derived: sum of 2 quarters · filed 2026-03-04
$4.42M
derived: sum of 3 quarters · filed 2026-03-04
$5.89M
derived: sum of 4 quarters · filed 2026-03-04
2023-12-31$1.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04
$2.99M
derived: sum of 2 quarters · filed 2026-03-04
$4.46M
derived: sum of 3 quarters · filed 2026-03-04
$5.85M
10-K · filed 2026-03-04
2023-09-30$1.45M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
$2.92M
derived: sum of 2 quarters · filed 2024-11-06
$4.32M
10-Q · filed 2024-11-06
$5.63M
derived: sum of 4 quarters · filed 2025-03-10
2023-06-30$1.47M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$2.86M
10-Q · filed 2024-08-07
$4.18M
derived: sum of 3 quarters · filed 2025-03-10
$5.49M
derived: sum of 4 quarters · filed 2025-03-10
2023-03-31$1.39M
10-Q · filed 2024-05-06
$2.71M
derived: sum of 2 quarters · filed 2025-03-10
$4.02M
derived: sum of 3 quarters · filed 2025-03-10
$5.29M
derived: sum of 4 quarters · filed 2025-03-10
2022-12-31$1.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10
$2.63M
derived: sum of 2 quarters · filed 2025-03-10
$3.90M
derived: sum of 3 quarters · filed 2025-03-10
$5.20M
10-K · filed 2025-03-10
2022-09-30$1.31M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
$2.58M
derived: sum of 2 quarters · filed 2023-11-01
$3.88M
10-Q · filed 2023-11-01
$5.19M
derived: sum of 4 quarters · filed 2023-11-01
2022-06-30$1.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$2.58M
10-Q · filed 2023-08-09
$3.88M
derived: sum of 3 quarters · filed 2023-08-09
$5.18M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$1.30M
10-Q · filed 2023-05-08
$2.61M
derived: sum of 2 quarters · filed 2023-05-08
$3.91M
derived: sum of 3 quarters · filed 2023-05-08
$5.15M
derived: sum of 4 quarters · filed 2023-05-08
2021-12-31$1.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02
$2.61M
derived: sum of 2 quarters · filed 2023-03-02
$3.84M
derived: sum of 3 quarters · filed 2023-03-02
$5.15M
10-K · filed 2023-03-02
2021-09-30$1.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01
$2.54M
derived: sum of 2 quarters · filed 2022-11-01
$3.85M
10-Q · filed 2022-11-01
$5.15M
derived: sum of 4 quarters · filed 2022-11-01
2021-06-30$1.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
$2.54M
10-Q · filed 2022-08-02
$3.84M
derived: sum of 3 quarters · filed 2022-08-02
$5.08M
derived: sum of 4 quarters · filed 2022-08-02
2021-03-31$1.31M
10-Q · filed 2022-05-03
$2.61M
derived: sum of 2 quarters · filed 2022-05-03
$3.84M
derived: sum of 3 quarters · filed 2022-05-03
$5.04M
derived: sum of 4 quarters · filed 2022-05-03
2020-12-31$1.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07
$2.54M
derived: sum of 2 quarters · filed 2022-03-07
$3.73M
derived: sum of 3 quarters · filed 2022-03-07
$4.88M
10-K · filed 2022-03-07
2020-09-30$1.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02
$2.43M
derived: sum of 2 quarters · filed 2021-11-02
$3.58M
10-Q · filed 2021-11-02
$4.49M
derived: sum of 4 quarters · filed 2021-11-02
2020-06-30$1.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03
$2.35M
10-Q · filed 2021-08-03
$3.25M
derived: sum of 3 quarters · filed 2021-08-03
$4.32M
derived: sum of 4 quarters · filed 2021-08-03
2020-03-31$1.15M
10-Q · filed 2021-05-03
$2.06M
derived: sum of 2 quarters · filed 2021-05-03
$3.12M
derived: sum of 3 quarters · filed 2021-05-03
$4.16M
derived: sum of 4 quarters · filed 2021-05-03
2019-12-31$908.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03
$1.97M
derived: sum of 2 quarters · filed 2021-03-03
$3.01M
derived: sum of 3 quarters · filed 2021-03-03
$3.89M
10-K · filed 2021-03-03
2019-09-30$1.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04
$2.10M
derived: sum of 2 quarters · filed 2020-11-04
$2.98M
10-Q · filed 2020-11-04
$3.78M
derived: sum of 4 quarters · filed 2020-11-04
2019-06-30$1.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04
$1.91M
10-Q · filed 2020-08-04
$2.72M
derived: sum of 3 quarters · filed 2020-08-04
$3.39M
derived: sum of 4 quarters · filed 2020-08-04
2019-03-31$880.00K
10-Q · filed 2020-05-05
$1.68M
derived: sum of 2 quarters · filed 2020-05-05
$2.36M
derived: sum of 3 quarters · filed 2020-05-05
2018-12-31$804.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04
$1.48M
derived: sum of 2 quarters · filed 2020-03-04
$2.70M
10-K · filed 2020-03-04
2018-09-30$672.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
$1.90M
10-Q · filed 2019-11-05
2018-06-30$1.23M
10-Q · filed 2019-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Park Dental Partners, Inc. (PARK)United States$0.094B
BioRestorative Therapies, Inc. (BRTX)United States$0.064B
CRYO CELL INTERNATIONAL INC (CCEL)United States$0.033B-11.02
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43
agilon health, inc. (AGL)United States$1.272B-7.76
Progyny, Inc. (PGNY)United States$1.994B28.37
Sotera Health Co (SHC)United States$5.271B30.96
DAVITA INC. (DVA)United States$11.147B16.80